Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease [NA]

View source ↗

Summary

This pediatric study investigates single-cell immune responses to controlled gluten exposure in children with celiac disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Celiac Disease, Gluten Sensitivity | NA | Status: RECRUITING